Literature DB >> 1688328

Widespread expression of BDNF but not NT3 by target areas of basal forebrain cholinergic neurons.

H S Phillips1, J M Hains, G R Laramee, A Rosenthal, J W Winslow.   

Abstract

Brain-derived neurotrophic factor (BDNF) and neurotrophin-3 (NT3) are homologs of the well-known neurotrophic factor nerve growth factor. The three members of this family display distinct patterns of target specificity. To examine the distribution in brain of messenger RNA for these molecules, in situ hybridization was performed. Cells hybridizing intensely to antisense BDNF probe were located throughout the major targets of the rat basal forebrain cholinergic system, that is, the hippocampus, amygdala, and neocortex. Strongly hybridizing cells were also observed in structures associated with the olfactory system. The distribution of NT3 mRNA in forebrain was much more limited. Within the hippocampus, labeled cells were restricted to CA2, the most medial portion of CA1, and the dentate gyrus. In human hippocampus, cells expressing BDNF mRNA are distributed in a fashion similar to that observed in the rat. These findings point to both basal forebrain cholinergic cells and olfactory pathways as potential central targets for BDNF.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1688328     DOI: 10.1126/science.1688328

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  82 in total

1.  Functionally antagonistic interactions between the TrkA and p75 neurotrophin receptors regulate sympathetic neuron growth and target innervation.

Authors:  J Kohn; R S Aloyz; J G Toma; M Haak-Frendscho; F D Miller
Journal:  J Neurosci       Date:  1999-07-01       Impact factor: 6.167

2.  Regulation of learning by EphA receptors: a protein targeting study.

Authors:  R Gerlai; N Shinsky; A Shih; P Williams; J Winer; M Armanini; B Cairns; J Winslow; W Gao; H S Phillips
Journal:  J Neurosci       Date:  1999-11-01       Impact factor: 6.167

Review 3.  Neurotrophic mechanisms in drug addiction.

Authors:  Carlos A Bolaños; Eric J Nestler
Journal:  Neuromolecular Med       Date:  2004       Impact factor: 3.843

Review 4.  Neuroprotection for amyotrophic lateral sclerosis: role of stem cells, growth factors, and gene therapy.

Authors:  Rachna S Pandya; Lilly L J Mao; Edward W Zhou; Robert Bowser; Zhenglun Zhu; Yongjin Zhu; Xin Wang
Journal:  Cent Nerv Syst Agents Med Chem       Date:  2012-03

Review 5.  Interactions of interleukin-1 with neurotrophic factors in the central nervous system: beneficial or detrimental?

Authors:  Wilma J Friedman
Journal:  Mol Neurobiol       Date:  2005-10       Impact factor: 5.590

6.  The trkB tyrosine protein kinase is a receptor for brain-derived neurotrophic factor and neurotrophin-3.

Authors:  R Klein; V Nanduri; S A Jing; F Lamballe; P Tapley; S Bryant; C Cordon-Cardo; K R Jones; L F Reichardt; M Barbacid
Journal:  Cell       Date:  1991-07-26       Impact factor: 41.582

7.  Impaired eye-blink conditioning in waggler, a mutant mouse with cerebellar BDNF deficiency.

Authors:  S Bao; L Chen; X Qiao; B Knusel; R F Thompson
Journal:  Learn Mem       Date:  1998 Sep-Oct       Impact factor: 2.460

8.  Promoter IV-BDNF deficiency disturbs cholinergic gene expression of CHRNA5, CHRM2, and CHRM5: effects of drug and environmental treatments.

Authors:  Kazuko Sakata; Abigail E Overacre
Journal:  J Neurochem       Date:  2017-08-16       Impact factor: 5.372

9.  Ampakines cause sustained increases in brain-derived neurotrophic factor signaling at excitatory synapses without changes in AMPA receptor subunit expression.

Authors:  J C Lauterborn; E Pineda; L Y Chen; E A Ramirez; G Lynch; C M Gall
Journal:  Neuroscience       Date:  2008-12-24       Impact factor: 3.590

10.  Septal cholinergic afferents regulate expression of brain-derived neurotrophic factor and beta-nerve growth factor mRNA in rat hippocampus.

Authors:  N Lindefors; P Ernfors; T Falkenberg; H Persson
Journal:  Exp Brain Res       Date:  1992       Impact factor: 1.972

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.